Rybelsus vs. Trulicity

See how Rybelsus and Trulicity compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Rybelsus is a daily pill while Trulicity is a once-weekly injection, so the choice often comes down to needle aversion versus a fasting-dependent tablet routine.

  • Both drugs are approved for blood sugar control in type 2 diabetes and for cardiovascular risk reduction, and both carry the same thyroid tumor boxed warning.

  • Trulicity is approved for children as young as 10, while Rybelsus is approved only for adults.

Rybelsus vs. Trulicity Drug Summary

Rybelsus

Rybelsus (semaglutide) is a GLP-1 receptor agonist used to control blood sugar in adults with type 2 diabetes and to lower cardiovascular risk in those with established heart disease. It is the only GLP-1 medicine available as a pill, taken once daily on an empty stomach. Some clinicians prescribe it off-label for weight loss.

Trulicity

Trulicity (dulaglutide) is a GLP-1 receptor agonist used to control blood sugar in people with type 2 diabetes, including children 10 and older, and to lower cardiovascular risk in adults with heart disease or multiple risk factors. It comes as a prefilled pen injected once a week under the skin. Some clinicians prescribe it off-label for weight loss.

Rybelsus vs. Trulicity Side Effects

Rybelsus

Most common
nausea (up to 20%)
abdominal pain (up to 11%)
diarrhea (up to 10%)
vomiting (up to 8%)

Trulicity

Most common
nausea (up to 21.1%)
abdominal pain (up to 13%)
diarrhea (up to 13%)
vomiting (up to 13%)

Rybelsus vs. Trulicity Dosage

Rybelsus

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 3 mg once daily Days 1-30
Maximum dose 14 mg once daily Day 61 onward
Dose changes 2 increases Every 30 days

Trulicity

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.75 mg once weekly Weeks 1-4
Maximum dose 4.5 mg once weekly If needed
Dose changes 3 increases Every 4 weeks

Rybelsus vs. Trulicity Indications

Rybelsus

Rybelsus is FDA-approved to improve blood sugar control in adults with type 2 diabetes and, as of an October 2025 label update, to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established heart disease. It is not approved for type 1 diabetes or for chronic weight management, though some doctors prescribe it off-label for weight loss.

  • Blood sugar control in adults with type 2 diabetes

  • Reduces risk of major cardiovascular events in adults with heart disease

  • Sometimes prescribed off-label for weight loss

  • Not approved for type 1 diabetes or chronic weight management

Trulicity

Trulicity is FDA-approved to improve blood sugar control in adults and children 10 and older with type 2 diabetes. It also reduces the risk of major cardiovascular events in adults with type 2 diabetes who have heart disease or multiple cardiovascular risk factors. It is not approved for type 1 diabetes or diabetic ketoacidosis, though it is sometimes used off-label for weight loss.

  • Blood sugar control in adults and children 10 and older

  • Reduces risk of major cardiovascular events in adults with heart disease or risk factors

  • Sometimes prescribed off-label for weight loss

  • Not approved for type 1 diabetes or diabetic ketoacidosis

Rybelsus vs. Trulicity Pros and Cons

Rybelsus

Rybelsus offers the only pill option among GLP-1 medicines, which appeals to people who want to avoid injections entirely. It requires strict dosing rules, taken first thing in the morning on an empty stomach with a small sip of water, waiting 30 minutes before eating or taking other medications. List price is comparable to Trulicity, so cost rarely decides between them.

Pros

  • Only GLP-1 medicine available as a swallowed pill

  • Daily dosing allows quicker adjustment if a dose is missed

  • No needles or injection training required

Cons

  • Must be taken on an empty stomach with minimal water

  • Must wait 30 minutes before other food, drinks, or medications

  • Not approved for use in children

Trulicity

Trulicity offers once-weekly dosing in a prefilled pen, which some people find simpler than a daily pill with fasting rules. It has the longest real-world track record of the major GLP-1 drugs, having been on the market since 2014. It is also one of the few GLP-1 medicines approved for children with type 2 diabetes.

Pros

  • Once-weekly injection with no fasting requirements

  • Approved for children 10 and older with type 2 diabetes

  • Longer track record on the market than Rybelsus

Cons

  • Requires a needle injection rather than a pill

  • No generic version available

  • Higher maintenance doses require moving to a new pen strength

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.